Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
- 19 November 1999
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 60 (1) , 48-55
- https://doi.org/10.1002/(sici)1096-9071(200001)60:1<48::aid-jmv9>3.0.co;2-e
Abstract
Parvovirus B19 is the causative agent of erythema infectiosum in children, but the virus is associated with an increasing range of different diseases. These include acute and chronic arthritis, hydrops fetalis in pregnant women, aplastic anemia, and thrombocytopenia. The host's immune response is directed against the viral structural proteins VP1 and VP2. This study investigated the presence of IgG against the viral nonstructural protein NS1 using Western blot. Serum panels from healthy individuals, B19-infected pregnant women, and various disease groups were tested. The disease groups included patients with symptoms that may be linked to parvovirus B19 infection. The results showed that IgG against the NS1 protein was present in 22% of healthy individuals with past B19 infection. In cases of persistent or prolonged B19 infections, the prevalence of NS1-specific antibodies was as high as 80%. It is concluded that NS1-specific IgG may be used as an indicator of chronic or more severe courses of parvovirus B19 infections. J. Med. Virol. 60:48–55, 2000.Keywords
This publication has 40 references indexed in Scilit:
- Viral arthritisCurrent Opinion in Rheumatology, 1997
- Sequence variability among different parvovirus B19 isolatesJournal of General Virology, 1996
- ReplyRheumatology, 1996
- Autoantibodies following Parvovirus B19 infectionJournal of Infection, 1996
- A new genome type of human parvovirus B19 present in sera of patients with encephalopathyJournal of General Virology, 1995
- Antibodies to parvovirus B19 NS-1 protein in infected individualsJournal of General Virology, 1995
- Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patientEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- The prevalence of antibody to human parvovirus B 19 in England and WalesJournal of Medical Microbiology, 1988
- Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus InfectionNew England Journal of Medicine, 1987
- HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTIONThe Lancet, 1985